These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14568226)

  • 1. Pure red cell aplasia--a rare disease with multiple causes.
    Djaldetti M; Blay A; Bergman M; Salman H; Bessler H
    Biomed Pharmacother; 2003 Oct; 57(8):326-32. PubMed ID: 14568226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible complications of erythropoietin therapy in patients with chronic renal failure].
    Pljesa S
    Med Pregl; 2004; 57(5-6):254-7. PubMed ID: 15503795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of pure red cell aplasia].
    Hirokawa M
    Rinsho Ketsueki; 2015 Oct; 56(10):1922-31. PubMed ID: 26458430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of acquired pure red cell aplasia.
    Sawada K; Hirokawa M; Fujishima N
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):249-59. PubMed ID: 19327582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
    Lim SK; Bee PC; Keng TC; Chong YB
    Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
    Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
    Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
    Janda K; Kraśniak A; Krzanowski M; Sułowicz W
    Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
    Wu X; Cheng L; Liu X; Sun Y; Li B; He G; Li J
    Ann Hematol; 2022 Jul; 101(7):1493-1498. PubMed ID: 35460389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the clinical management of pure red cell aplasia and future prospects].
    Hirokawa M
    Rinsho Ketsueki; 2016 Feb; 57(2):110-6. PubMed ID: 26935627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.
    Vlachaki E; Diamantidis MD; Klonizakis P; Haralambidou-Vranitsa S; Ioannidou-Papagiannaki E; Klonizakis I
    ScientificWorldJournal; 2012; 2012():475313. PubMed ID: 22593689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The problem of acquired aplastic anaemia].
    Solignac M;
    Presse Med; 2003 Sep; 32(29):1378-80. PubMed ID: 14534504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory anemia in human immunodeficiency virus: Expect the unexpected.
    Mirgh SP; Mishra VA; Shah VD; Sorabjee JS
    J Family Med Prim Care; 2016; 5(3):727-729. PubMed ID: 28217621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
    Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
    J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of pure red cell aplasia in US dialysis patients: the limits of the Medicare data.
    Collins AJ; Li S; Adamson JW; Gilbertson DT
    Am J Kidney Dis; 2004 Mar; 43(3):464-70. PubMed ID: 14981604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired pure red cell aplasia: updated review of treatment.
    Sawada K; Fujishima N; Hirokawa M
    Br J Haematol; 2008 Aug; 142(4):505-14. PubMed ID: 18510682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
    Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
    Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and management of pure red cell aplasia].
    Fujishima N
    Rinsho Ketsueki; 2021; 62(8):931-937. PubMed ID: 34497233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed spontaneous remission in a child with primary acquired chronic pure red cell aplasia.
    Khalil A; Elhasid R; Ben Barak A; Ben Arush MW
    Pediatr Hematol Oncol; 2010 Oct; 27(7):574-80. PubMed ID: 20615070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Carson KR; Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.